Related references
Note: Only part of the references are listed.Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold et al.
GUT (2017)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
Takuro Saito et al.
NATURE MEDICINE (2016)
Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients
May Abd Al Samid et al.
Oncotarget (2016)
Helios Should Not Be Cited as a Marker of Human Thymus-Derived Tregs. Commentary: Helios+ and Helios- Cells Coexist within the Natural FoXP3+ T Regulatory Cell Subset in Humans
Eyad Elkord
FRONTIERS IN IMMUNOLOGY (2016)
Increased Levels of Circulating and Tumor-Infiltrating Granulocytic Myeloid Cells in Colorectal Cancer Patients
Salman M. Toor et al.
FRONTIERS IN IMMUNOLOGY (2016)
Regulatory T cells with multiple suppressive and potentially pro-tumor activities accumulate in human colorectal cancer
Eleonora Timperi et al.
ONCOIMMUNOLOGY (2016)
Enrichment of Inflammatory IL-17 and TNF-α Secreting CD4+ T Cells within Colorectal Tumors despite the Presence of Elevated CD39+ T Regulatory Cells and Increased Expression of the Immune Checkpoint Molecule, PD-1
Margaret R. Dunne et al.
Frontiers in Oncology (2016)
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
Belal Chaudhary et al.
VACCINES (2016)
Stable inhibitory activity of regulatory T cells requires the transcription factor Helios
Hye-Jung Kim et al.
SCIENCE (2015)
Helios, and not FoxP3, is the marker of activated Tregs expressing GARP/LAP
Eyad Elkord et al.
ONCOTARGET (2015)
CTLA-4 and PD-1 pathway blockade: combinations in the clinic
Margaret K. Callahan et al.
FRONTIERS IN ONCOLOGY (2015)
Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3- T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells
M. Scurr et al.
MUCOSAL IMMUNOLOGY (2014)
Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients
H-B Jie et al.
BRITISH JOURNAL OF CANCER (2013)
Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
Jaikumar Duraiswamy et al.
CANCER RESEARCH (2013)
At the Bedside: CTLA-4-and PD-1-blocking antibodies in cancer immunotherapy
Margaret K. Callahan et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
ENTPD1/CD39 is a promising therapeutic target in oncology
J. Bastid et al.
ONCOGENE (2013)
Home sweet home: the tumor microenvironment as a haven for regulatory T cells
Beatrice Ondondo et al.
FRONTIERS IN IMMUNOLOGY (2013)
Phenotypic and functional characteristics of CD4+CD39+FOXP3+ and CD4+CD39+FOXP3neg T-cell subsets in cancer patients
Patrick J. Schuler et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer
Gareth Betts et al.
GUT (2012)
Comment on Expression of Helios in Peripherally Induced Foxp3+ Regulatory T Cells
Eyad Elkord
JOURNAL OF IMMUNOLOGY (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
Sylvain Ladoire et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells
Sameena Khan et al.
CLINICAL IMMUNOLOGY (2011)
Helios Expression Is a Marker of T Cell Activation and Proliferation
Tatiana Akimova et al.
PLOS ONE (2011)
CD39/Adenosine Pathway Is Involved in AIDS Progression
Maria Nikolova et al.
PLOS PATHOGENS (2011)
Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer
Yan Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2010)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells
Magis Mandapathil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Comment on Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3+ T Regulatory Cells
Johan Verhagen et al.
JOURNAL OF IMMUNOLOGY (2010)
Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3(+) T Regulatory Cells
Angela M. Thornton et al.
JOURNAL OF IMMUNOLOGY (2010)
A role for the transcription factor Helios in human CD4+CD25+ regulatory T cells
Derese Getnet et al.
MOLECULAR IMMUNOLOGY (2010)
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
Michael A. Curran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
Makoto Miyara et al.
IMMUNITY (2009)
PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4(+)CD25(Hi) regulatory T cells
Wenshi Wang et al.
INTERNATIONAL IMMUNOLOGY (2009)
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells:: hydrolysis of extracellular ATP and immune suppression
Giovanna Borsellino et al.
BLOOD (2007)
Tumor evasion of the immune system by converting CD4+ CD25- T cells into CD4+ CD25+ T regulatory cells:: Role of tumor-derived TGF-β
Victoria C. Liu et al.
JOURNAL OF IMMUNOLOGY (2007)
CD4+ CD25+ FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer
Sarah L. Clarke et al.
PLOS ONE (2006)
Blockade of CTLA-4 on CD4+ CD25+ regulatory T cells abrogates their function in vivo
Simon Read et al.
JOURNAL OF IMMUNOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Share Paper
